The startup, which is backed by a dozen investors including Merck & Co., claims its novel “linkers” can help address some of ...
A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback